Health Condition 1: K089- Disorder of teeth and supporting structures, unspecified Health Condition 2: M266- Temporomandibular joint disorders
Conditions
Interventions
Intervention1: INTERVENTION - PROLOTHERAPY: 2ML OF 25% DEXTROSE AND 0.5ML 3%SODIUM TETRADECYL SULPHATE ONCE EVERY 4 WEEKS FOR 4 SESSIONS
Control Intervention1: prolotherapy in tmj hypermobilty with 3%
Sponsors
Dr Pimple Subham
Dr Phani Kumar K
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with functional temporomandibular joint disorders including Internal Derangement, Subluxation and Dislocation. 2. Patients who are willing to participate in the study and give their consent
Exclusion criteria
Exclusion criteria: 1. Subjects under Anticoagulation therapy 2. Subjects with a History of total TMJ replacement, 3. Subjects with a Prior TMJ prolotherapy in the past 6 months 4. Subjects with TMJ injection within the past 3 months 5. Patients with concomitant inflammatory or infectious disorders of the TMJ 6. Patients with Daily use of opioid medication 7. Patients with Allergy or intolerance to study injections or pain medications 8. Patients with Connective tissue disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EVALUATION OF EFFICACY OF 3% SODIUM TETRADECYL SULPHATE AND 25% DEXTROSE IN TREATMENT OF TEMPOROMANDIBULAR JOINT HYPERMOBILITYTimepoint: 18 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| to determine the better treatment intervention between 25% dextrose prolotherapy and 3% sodium tetradecyl sulphateTimepoint: 18 months | — |
Countries
India
Contacts
Public ContactDr I Nagamalleswar Rao
Anil Neerukonda Institute Of Dental Sciences.
Outcome results
None listed